171 related articles for article (PubMed ID: 37650260)
21. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Zheng M; Han QD; Xiao RP
Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart.
Yin F; Li P; Zheng M; Chen L; Xu Q; Chen K; Wang YY; Zhang YY; Han C
J Biol Chem; 2003 Jun; 278(23):21070-5. PubMed ID: 12665506
[TBL] [Abstract][Full Text] [Related]
23. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling.
Pillai VB; Sundaresan NR; Kim G; Samant S; Moreno-Vinasco L; Garcia JG; Gupta MP
Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H415-26. PubMed ID: 23203961
[TBL] [Abstract][Full Text] [Related]
24. Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts.
Zou Y; Komuro I; Yamazaki T; Kudoh S; Aikawa R; Zhu W; Shiojima I; Hiroi Y; Tobe K; Kadowaki T; Yazaki Y
Circ Res; 1998 Feb; 82(3):337-45. PubMed ID: 9486662
[TBL] [Abstract][Full Text] [Related]
25. Src mediates β-adrenergic receptor induced YAP tyrosine phosphorylation.
Wang W; Li W; Liu K; Niu X; Guan K; Jiang Y; Li Z; Dong E
Sci China Life Sci; 2020 May; 63(5):697-705. PubMed ID: 32246402
[TBL] [Abstract][Full Text] [Related]
26. Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivo.
Puhl SL; Weeks KL; Güran A; Ranieri A; Boknik P; Kirchhefer U; Müller FU; Avkiran M
Cardiovasc Res; 2019 Mar; 115(3):519-529. PubMed ID: 30203051
[TBL] [Abstract][Full Text] [Related]
27. Molecular basis of cardiac hypertrophy.
Yamazaki T; Yazaki Y
Z Kardiol; 2000 Jan; 89(1):1-6. PubMed ID: 10663910
[TBL] [Abstract][Full Text] [Related]
28. Ataxia telangiectasia mutated kinase plays a protective role in β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.
Foster CR; Singh M; Subramanian V; Singh K
Mol Cell Biochem; 2011 Jul; 353(1-2):13-22. PubMed ID: 21404020
[TBL] [Abstract][Full Text] [Related]
29. Effects of β-adrenergic receptor drugs on embryonic ventricular cell proliferation and differentiation and their impact on donor cell transplantation.
Feridooni T; Hotchkiss A; Baguma-Nibasheka M; Zhang F; Allen B; Chinni S; Pasumarthi KBS
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H919-H931. PubMed ID: 28283550
[TBL] [Abstract][Full Text] [Related]
30. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
Major JL; Salih M; Tuana BS
J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
[TBL] [Abstract][Full Text] [Related]
31. HIP-55/DBNL-dependent regulation of adrenergic receptor mediates the ERK1/2 proliferative pathway.
Liu N; Xing R; Yang C; Tian A; Lv Z; Sun N; Gao X; Zhang Y; Li Z
Mol Biosyst; 2014 Jul; 10(7):1932-9. PubMed ID: 24802081
[TBL] [Abstract][Full Text] [Related]
32. The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications.
Cotecchia S; Del Vescovo CD; Colella M; Caso S; Diviani D
Cell Signal; 2015 Oct; 27(10):1984-93. PubMed ID: 26169957
[TBL] [Abstract][Full Text] [Related]
33. Sustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation.
Nuamnaichati N; Sato VH; Moongkarndi P; Parichatikanond W; Mangmool S
Life Sci; 2018 Jan; 193():257-269. PubMed ID: 29107793
[TBL] [Abstract][Full Text] [Related]
34. JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytes.
Xu J; Liang S; Wang Q; Zheng Q; Wang M; Qian J; Yu T; Lou S; Luo W; Zhou H; Liang G
Cell Mol Life Sci; 2024 Jan; 81(1):18. PubMed ID: 38195959
[TBL] [Abstract][Full Text] [Related]
35. Cardiac β-adrenergic receptor activation mediates distinct and cell type-dependent changes in the expression and distribution of connexin 43.
Zhang Y; Hou MC; Li JJ; Qi Y; Zhang Y; She G; Ren YJ; Wu W; Pang ZD; Xie W; Deng XL; Du XJ
J Cell Mol Med; 2020 Aug; 24(15):8505-8517. PubMed ID: 32578931
[TBL] [Abstract][Full Text] [Related]
36. β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.
Murray DR; Mummidi S; Valente AJ; Yoshida T; Somanna NK; Delafontaine P; Dinarello CA; Chandrasekar B
J Mol Cell Cardiol; 2012 Jan; 52(1):206-18. PubMed ID: 22004899
[TBL] [Abstract][Full Text] [Related]
37. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction.
Chen S; Zhang Y; Lighthouse JK; Mickelsen DM; Wu J; Yao P; Small EM; Yan C
Circulation; 2020 Jan; 141(3):217-233. PubMed ID: 31801360
[TBL] [Abstract][Full Text] [Related]
38. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
39. Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.
Ge W; Hou C; Zhang W; Guo X; Gao P; Song X; Gao R; Liu Y; Guo W; Li B; Zhao H; Wang J
J Mol Cell Cardiol; 2021 Mar; 152():52-68. PubMed ID: 33301800
[TBL] [Abstract][Full Text] [Related]
40. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
